Centene Corporation (CNC) Q2 2025 10-Q Quarterly Report
Centene Corporation (CNC) 10-Q quarterly report for Q2 2025, filed with SEC EDGAR on Jul 25, 2025 for the fiscal period ending Jun 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.
Centene Corporation Q2 2025 10-Q Analysis
Risk Factors
- • New risk: 2025 Marketplace morbidity higher than expected due to independent actuarial data and increased Medicaid costs in behavioral health and drugs
- • Most updated risk: Expiration of COVID-19 Public Health Emergency increased Medicaid member acuity, raising health benefits ratio and delaying adequate rate adjustments
Centene Corporation Q2 2025 Quarterly FinancialsXBRL
Revenue
$42.5B
▲ +18.1% YoY▼ -0.1% QoQ
Net Income
-$253M
▼ -122.1% YoY▼ -119.3% QoQ
Gross Margin
7.1%
▼ -548bp YoY▼ -534bp QoQ
Operating Margin
-1.1%
▼ -449bp YoY▼ -469bp QoQ
Net Margin
-0.6%
▼ -378bp YoY▼ -368bp QoQ
EPS (Diluted)
$-0.50
▼ -123.1% YoY▼ -119.0% QoQ
Operating Cash Flow
$1.8B
▼ -17.9% YoY▲ +18.2% QoQ
Source: XBRL data from Centene Corporation Q2 2025 10-Q filing on SEC EDGAR. All figures in USD.
Other Centene Corporation Quarterly Reports
Get deeper insights on Centene Corporation
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.